Budesonide/Formoterol Added to Tiotropium Is Well Tolerated and Reduces Risk of Severe Exacerbations in COPD Patients.

被引：0
|
作者：
Welte, T.
Hartman, L. [1 ]
Polanowski, T. [1 ]
Hernandez, P.
机构：
[1] AZ, Lund, Sweden
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6188
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
    Calverley, Peter M.
    Eriksson, Goran
    Jenkins, Christine R.
    Anzueto, Antonio R.
    Make, Barry J.
    Persson, Anders
    Fageras, Malin
    Postma, Dirkje S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 13 - 25
  • [22] Efficacy and tolerability of budesonide/formoterol (B/F) added to tiotropium (T) vs T alone in East-Asia patients (pts) with severe/very severe chronic obstructive pulmonary disease (COPD)
    Lee, Sang Do
    Xie, Can-mao
    Yunus, Faisal
    Itoh, Yohji
    Su, Rong
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [23] ECONOMIC EVALUATION OF INDACATEROL VERSUS TIOTROPIUM OR FORMOTEROL FOR PATIENTS WITH MODERATE TO SEVERE COPD IN GREECE
    Geitona, M.
    Hatzikou, M.
    Bania, E.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
  • [24] FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations
    Agusti, Alvar
    Corradi, Massimo
    Cohuet, Geraldine
    Vezzoli, Stefano
    Singh, Dave
    Vestbo, Jorgen
    Paggiaro, Pierluigi
    Jones, Paul
    Petruzzelli, Stefano
    Wedzicha, Jawidga
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [25] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary DiseaseAustralian, Canadian and Swedish Healthcare Perspectives
    Nicole Mittmann
    Paul Hernandez
    Carl Mellström
    Lance Brannman
    Tobias Welte
    PharmacoEconomics, 2011, 29 : 403 - 414
  • [26] EFFICACY AND TOLERABILITY OF BUDESONIDE/FORMOTEROL ADDED TO IPRATROPIUM PLUS THEOPHYLLINE IN SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Wang, Chen
    Guo, Yanfei
    Huang, Kewu
    RESPIROLOGY, 2013, 18 : 179 - 179
  • [27] QVA149 Improves Lung Function and Reduces Exacerbations Compared With Tiotropium in Patients With Severe-to-Very Severe COPD: The SPARK Study
    Ficker, Joachim
    Wedzicha, Jadwiga
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [28] QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study
    Ficker, Joachim H.
    Wedzicha, Jadwiga A.
    Decramer, Marc
    FowlerTaylor, Angel
    D'Andrea, Peter
    Arrasate, Christie
    Chen, Hungta
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [29] A RANDOMISED CONTROLLED TRIAL OF SINGLE COMBINATION BUDESONIDE/FORMOTEROL INHALER AS MAINTENANCE AND RELIEVER THERAPY IN ASTHMA PATIENTS AT RISK OF SEVERE EXACERBATIONS
    Patel, M.
    Pilcher, J.
    Shaw, D.
    Weatherall, M.
    Beasley, R.
    THORAX, 2013, 68 : A148 - A148
  • [30] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease Australian, Canadian and Swedish Healthcare Perspectives
    Mittmann, Nicole
    Hernandez, Paul
    Mellstrom, Carl
    Brannman, Lance
    Welte, Tobias
    PHARMACOECONOMICS, 2011, 29 (05) : 403 - 414
12345